Changing Business Models: Durability and Reimbursement

The cost of healthcare remains a significant challenge, but we believe that innovative treatments, such as viral and cell-based gene therapies, have the potential to transform patient treatment and the healthcare industry at large. These therapies come at steep initial price points but, over the long term, may lower a patient’s lifetime cost of care.